Assessment of efficacy and safety of ezetimibe in patients with dyslipidemia complicated insulin resistance.
Latest Information Update: 27 Dec 2019
At a glance
- Drugs Ezetimibe (Primary)
- Indications Dyslipidaemias; Insulin resistance
- Focus Adverse reactions; Therapeutic Use
- 13 Dec 2019 Status changed from recruiting to completed.
- 23 Jun 2011 New trial record